Protective role for the disulfide isomerase PDIA3 in methamphetamine neurotoxicity

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Pendyala, Gurudutt ^a   Ninemire, Carly ^a   Fox, Howard S ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE FAMILY MEMBER A3; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; CENTRAL STIMULANT AGENT; PDIA3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION PROFILING; HIPPOCAMPUS; IN VITRO STUDY; MALE; MOUSE; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; RAT; RHESUS MONKEY; UPREGULATION; ANIMAL; BIOSYNTHESIS; ENZYMOLOGY; FEMALE; HUMAN; NEUROTOXICITY SYNDROMES; PATHOLOGY; SUBSTANCE-RELATED DISORDERS; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HIPPOCAMPUS; HUMANS; MACACA MULATTA; MALE; METHAMPHETAMINE; MICE; NEUROTOXICITY SYNDROMES; PROTEIN DISULFIDE-ISOMERASES; SUBSTANCE-RELATED DISORDERS;

EID: 84862021637     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038909     Document Type: Article

References (23)

1. Cadet JL, Krasnova IN, (2009) Molecular bases of methamphetamine-induced neurodegeneration. Int Rev Neurobiol 88: 101 119.
2. Yamamoto BK, Moszczynska A, Gudelsky GA, (2010) Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci 1187: 101 121.
3. Harvey DC, Lacan G, Melegan WP, (2000) Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure. Exp Brain Res 133: 349 358.
4. Harvey DC, Lacan G, Tanious SP, Melega WP, (2000) Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res 871: 259 270.
5. Melega WP, Jorgensen MJ, Lacan G, Way BM, Pham J, (2008) Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles. Neuropsychopharmacology 33: 1441 1452.
6. Woolverton WL, Ricaurte GA, Forno LS, Seiden LS, (1989) Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res 486: 73 78.
7. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2: 699 703.
8. Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, (1996) Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol 40: 428 439.
9. Jayanthi S, McCoy MT, Beauvais G, Ladenheim B, Gilmore K, (2009) Methamphetamine induces dopamine D1 receptor-dependent endoplasmic reticulum stress-related molecular events in the rat striatum. PLoS One 4: e6092.
10. Degenhardt L, Mathers B, Guarinieri M, Panda S, Phillips B, (2010) Meth/amphetamine use and associated HIV: Implications for global policy and public health. Int J Drug Policy 21: 347 358.
11. Marcondes MC, Flynn C, Watry DD, Zandonatti M, Fox HS, (2010) Methamphetamine increases brain viral load and activates natural killer cells in simian immunodeficiency virus-infected monkeys. The American Journal of Pathology 177: 355 361.
12. Burdo TH, Marcondes MC, Lanigan CM, Penedo MC, Fox HS, (2005) Susceptibility of Chinese rhesus monkeys to SIV infection. Aids 19: 1704 1706.
13. Watry D, Lane TE, Streb M, Fox HS, (1995) Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia. Am J Pathol 146: 914 923.
14. Huang da W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1 13.
15. Marcondes MC, Burdo TH, Sopper S, Huitron-Resendiz S, Lanigan C, (2007) Enrichment and persistence of virus-specific CTL in the brain of simian immunodeficiency virus-infected monkeys is associated with a unique cytokine environment. J Immunol 178: 5812 5819.
16. Hetz C, Russelakis-Carneiro M, Walchli S, Carboni S, Vial-Knecht E, (2005) The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci 25: 2793 2802.
17. Erickson RR, Dunning LM, Olson DA, Cohen SJ, Davis AT, (2005) In cerebrospinal fluid ER chaperones ERp57 and calreticulin bind beta-amyloid. Biochem Biophys Res Commun 332: 50 57.
18. Mazzarella RA, Marcus N, Haugejorden SM, Balcarek JM, Baldassare JJ, (1994) Erp61 is GRP58, a stress-inducible luminal endoplasmic reticulum protein, but is devoid of phosphatidylinositide-specific phospholipase C activity. Arch Biochem Biophys 308: 454 460.
19. Jayanthi S, Deng X, Noailles PA, Ladenheim B, Cadet JL, (2004) Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB J 18: 238 251.
20. Kuroda KO, Ornthanalai VG, Kato T, Murphy NP, (2010) FosB null mutant mice show enhanced methamphetamine neurotoxicity: potential involvement of FosB in intracellular feedback signaling and astroglial function. Neuropsychopharmacology 35: 641 655.
21. Xie T, Tong L, Barrett T, Yuan J, Hatzidimitriou G, (2002) Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity. J Neurosci 22: 274 283.
22. Hirano N, Shibasaki F, Sakai R, Tanaka T, Nishida J, (1995) Molecular cloning of the human glucose-regulated protein ERp57/GRP58, a thiol-dependent reductase. Identification of its secretory form and inducible expression by the oncogenic transformation. Eur J Biochem 234: 336 342.
23. Berman S, O'Neill J, Fears S, Bartzokis G, London ED, (2008) Abuse of amphetamines and structural abnormalities in the brain. Ann N Y Acad Sci 1141: 195 220.